Abstract:In China, hepatocellular carcinoma (HCC) usually develops following a long history of chronic hepatitis B infection or cirrhosis. To evaluate the diagnostic role of annexin A2 (ANXA2), a possible tumor marker, in patients with hepatitis B virus (HBV)-related HCC, particularly those with a history of cirrhosis, the present study prospectively enrolled 87 patients with HBV-related HCC (with cirrhosis), 39 patients with HBV-related cirrhosis and 27 healthy controls. The expression levels of serum and tissue ANXA2 were determined using an enzyme-linked immunosorbent assay (ELISA) and immunohistochemical staining, respectively. The serum levels of ANXA2 were significantly elevated in the patients with HCC (median, 567.2 mu g/ml; P=0.003) and cirrhosis (median, 414.8 mu g/ml; P=0.011) compared with the healthy controls (median, 241.9 mu g/ml). However, no significant differences were observed in the serum ANXA2 levels between the patients with HCC and those with cirrhosis. The immunohistochemical staining analysis showed that the healthy controls did not show positive staining, while the number of cases immunoreactive for ANXA2 steadily increased from the liver cirrhosis tissues (20/39, 51.3%) to the non-cancer (53/87, 60.9%) and cancer tissues (68/87, 78.2%). The cancer tissues exhibited a significantly higher ANXA2-positive rate compared with the non-cancer (P=0.013) and liver cirrhosis tissues (P=0.002). Furthermore, marked ANXA2 staining was more prevalent in the cancer tissues (16/87, 18.4%) than the non-cancer (4/87, 4.6%; P=0.004) and liver cirrhosis (1/39, 2.6%; P=0.034) tissues. The sensitivity, specificity and diagnostic accuracy of tissue ANXA2 for HCC in cirrhosis were 78.2, 42.1 and 56.8%, respectively. The ANXA2 expression levels in the serum and cancer tissues were not associated with tumor-free survival or patient survival following liver transplantation. Serum or tissue ANXA2 is not a good diagnostic marker for HCC in HBV-related cirrhosis and is not associated with prognosis.

Upregulation Expressions and Clinical Significances of Annexin Ⅱ in Human Hepatocellular Carcinoma

Up-regulated Expression of Annexin Ⅱ Protein in Human Gastric Adenocarcinoma Tissues and Its Clinical Significances

Expression and Significance of Annexin A2 in Patients with Gastric Adenocarcinoma and the Association with E-cadherin.

Annexin A2 is Not A Good Biomarker for Hepatocellular Carcinoma in Cirrhosis

[Effects of Annexin A2 gene transcription down-regulation on human hepatoma cell biological behaviour]

Phospholipase A2 group ⅡA mRNA expression in human hepatocellular carcinoma and its clinical significance

Annexin II Promotes Invasion and Migration of Human Hepatocellular Carcinoma Cells in Vitro Via Its Interaction with HAb18G/CD147

Clinical Limitations of Tissue Annexin A2 Level as a Predictor of Postoperative Overall Survival in Patients with Hepatocellular Carcinoma

[The Expression and Clinical Significance of Annexin II in Clear-Cell Renal Cell Carcinoma].

[Dysregulation of Annexin II Expression in Esophageal Squamous Cell Cancer and Adjacent Tissues from a High-Incidence Area for Esophageal Cancer in Henan Province].

Relationship Between the Expressions of Coagulation Factor Ⅱ Gene in Hepatocellular Carcinoma and Their Clinical Intexes

Overexpression of annexin A4 indicates poor prognosis and promotes tumor metastasis of hepatocellular carcinoma

Increased expression of Annexin A2 in oral squamous cell carcinoma.

Clinical Significance of High Expression of Stanniocalcin-2 in Hepatocellular Carcinoma

[An Analysis of Annexin II Related to HCC Metastatic Ability].

Expression of Ankyrin 2 in Hepatocellular Carcinoma is Dysregulated and Affects the Prognosis of Hepatocellular Carcinoma Patients

Expression and its Signifcance of Annexin Ⅱ in human gastric adenocarcinoma

Annexin-1 Downregulation is Associated with Clinical Outcome in Chinese Patients with Hilar Cholangiocarcinoma

Significance and Expression of CXC Chemokine Receptor 2 in Human Hepatocellular Carcinoma

The Expression of CIP2A in Hepatocellular Carcinoma and Its Clinical Significance

The correlations between the expression of annexin Ⅱ and clinicopathologic features as well as prognosis of prostate cancer